Related Experiment Video

Updated: May 19, 2026

Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells
08:42

Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells

Published on: January 15, 2018

Insertion of a nuclear factor kappa B DNA nuclear-targeting sequence potentiates suicide gene therapy efficacy in

F Cramer1, C L Christensen, T T Poulsen

  • 1Department of Radiation Biology, Copenhagen University Hospital, Copenhagen, Denmark.

Cancer Gene Therapy
|August 18, 2012
PubMed

Insights

Researchers enhanced lung cancer gene therapy by improving DNA delivery to cancer cells. Utilizing the NFκB system

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Lung cancer is a leading cause of cancer mortality globally, necessitating novel therapeutic strategies.
  • Current gene therapy for lung cancer faces limitations due to inefficient cellular and nuclear DNA delivery.
  • The nuclear factor kappa B (NFκB) system is highly active in many cancers, including lung cancer.

Purpose of the Study:

  • To investigate the potential of exploiting the NFκB system's nuclear-shuttling activity to enhance gene therapy efficiency in lung cancer.
  • To determine if a DNA nuclear-targeting sequence (DTS) recognized by NFκB can improve plasmid delivery and therapeutic outcomes.

Main Methods:

  • Insertion of a DNA nuclear-targeting sequence (DTS) into a transcriptionally cancer-targeted suicide gene therapy system.
  • Evaluation of plasmid nuclear delivery and therapeutic efficacy in small cell lung cancer (SCLC) and non-SCLC cell lines.
  • Correlation analysis between the number of NFκB-binding sites and therapeutic effect.

Main Results:

  • The engineered suicide gene therapy system demonstrated improved plasmid nuclear delivery.
  • A direct correlation was observed between the number of inserted NFκB-binding sites and enhanced therapeutic effects in both SCLC and non-SCLC.
  • Elevated nuclear translocation of suicide gene-encoding plasmids was identified as the mechanism for improved efficacy.

Conclusions:

  • Exploiting the NFκB system with a DTS significantly enhances gene therapeutic efficiency by improving intracellular DNA trafficking.
  • This study presents the first implementation of a DTS strategy for suicide gene therapy.
  • The findings offer a promising approach to overcome current limitations in gene therapy for lung cancer.

More Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia09:52

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia

Published on: December 4, 2018

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...